Top Abstract Purchase Related
Home
>
Node
>
Subnode

Gateways to clinical trials

Bayés, M.; Rabasseda, X.; Prous, J.R.

Methods and Findings in Experimental and Clinical Pharmacology 29(4): 303-311

2007

ISSN/ISBN: 0379-0355
PMID: 17609744
Document Number: 607041
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com. This issues focuses on the following selection of drugs: (-)-Epigallocatechin gallate, 101M, AAV-AADC, AGN-201904-Z; Agomelatine, AN-0128, AN-2690, Arginine butyrate, Asenapine maleate; Belinostat, Bortezomib, BQ-123, BQ-788; Bucindolol hydrochloride; Certolizumab pegol; Dasatinib, Denosumab, Desvenlafaxine succinate; Ecogramostim, Esomeprazole magnesium; Homoharringtonine; huN901-DM1, Hyaluronic acid; Incyclinide; L-Arginine hydrochloride; Mepolizumab; Nematode anticoagulant protein c2, Nilotinib; Oblimersen sodium; R-115866, Raltegravir potassium, Retapamulin, Romidepsin, Rusalatide acetate; Sarcosine, SCIO-469, Soblidotin, Sorivudine; Tilarginine hydrochloride, Tipifarnib; Uracil; Vildagliptin.

Document emailed within 1 workday
Secure & encrypted payments

Bayés, M.; Rabasseda, X.; Prous, J.R. 2004: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 26(2): 129-161
Bayes, M.; Rabasseda, X.; Prous, J.R. 2006: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 28(6): 379-412
Bayés, M.; Rabasseda, X.; Prous, J.R. 2005: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 27(3): 193-219
Bayes, M.; Rabasseda, X.; Prous, J.R. 2002: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 24(1): 37-55
Tomillero, A.; Moral, M.A. 2009: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 31(10): 661-700
Bayes, M.; Rabasseda, X.; Prous, J.R. 2003: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 25(9): 747-771
Moral, M.A.; Tomillero, A. 2008: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 30(2): 149-171
Bayes, M.; Rabasseda, X.; Prous, J.R. 2004: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 26(4): 295-318
Bayés, M.; Rabasseda, X.; Prous, J.R. 2004: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 26(10): 801-827
Tomillero, A.; Moral, M.A. 2009: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 31(6): 397-417
Bayes, M.; Rabasseda, X.; Prous, J.R. 2004: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 26(5): 357-391
Bayés, M.; Rabasseda, X.; Prous, J.R. 2002: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 24(6): 371-391
Bayés, M.; Rabasseda, X.; Prous, J.R. 2002: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 24(8): 525-551
Bayes, M.; Rabasseda, X.; Prous, J.R. 2004: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 26(7): 587-612
Bayés, M.; Rabasseda, X.; Prous, J.R. 2003: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 25(7): 565-597
Bayés, M.; Rabasseda, X.; Prous, J.R. 2007: Gateways to clinical trials Methods and Findings in Experimental and Clinical Pharmacology 29(6): 427-437
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443